Medical Condition News

RSS

Study finds ketamine restores connection in chronic stress affected brain cells

Yale researchers have discovered how a novel anti-depressant can take effect in hours, rather than the weeks or months usually required for most drugs currently on the market.

20 Aug 2010

Pulmonary Fibrosis Foundation to support 2010 National PF Week

The Pulmonary Fibrosis Foundation (PFF) today expressed its support for the 2010 National Pulmonary Fibrosis Awareness Week activities, to be held from September 11-18, 2010 in Washington D.C.

20 Aug 2010

Bacterial pathogens require vitamin B6 biosynthesis enzymes for virulence: Study

Scientists have determined that Helicobacter pylori, the bacterium that causes peptic ulcers and some forms of stomach cancer, requires the vitamin B6 to establish and maintain chronic infection, according to research published this week in the online journal mBio-. This finding, along with the identification of the enzyme the microbe requires to utilize the vitamin, could lead to the development of an entirely new class of antibiotics.

20 Aug 2010

Palliative care recipients live longer and in less pain, study finds

The New York Times: "In a study that sheds new light on the effects of end-of-life care, doctors have found that patients with terminal lung cancer who began receiving palliative care immediately upon diagnosis not only were happier, more mobile and in less pain as the end neared — but they also lived nearly three months longer.

20 Aug 2010

Scientists discover genetic flaw that causes facioscapulohumeral muscular dystrophy

Nearly two decades after they identified the specific genetic flaw that causes a common type of muscular dystrophy, scientists believe they have figured out how that flaw brings about the disease. The finding by an international team of researchers settles a longstanding question about the roots of facioscapulohumeral muscular dystrophy or FSHD.

20 Aug 2010

FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta

The U.S. Food and Drug Administration (FDA) Anesthetic and Life Support Drugs Advisory Committee voted 8-6 in favor of expanding the pain indications for Eli Lilly and Company's (NYSE: LLY) Cymbalta® (duloxetine HCl) to a broader pain population that will be further defined by the FDA, if approved.

20 Aug 2010

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.

20 Aug 2010

Study finds black women with SLE develop cardiovascular disease at early age

A recent study by researchers at Penn State College of Medicine found significant racial disparities in the age of systemic lupus erythematosus (SLE) patients at the time of hospital admission for cardiovascular disease (CVD) events and CVD-related death. Black women were youngest to both be admitted with CVD and to have an in-hospital death due to CVD.

20 Aug 2010

Renin test can predict appropriate drugs for BP patients: Study

Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect-raising blood pressure in a statistically significant percentage of patients. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that doctors could avoid this problem-and select drugs most suitable for their patients-by measuring blood levels of the enzyme renin through a blood test that is becoming more widely available. The study appears in the online edition of the American Journal of Hypertension.

20 Aug 2010

Study suggests elective surgical repair is safe intervention for abdominal aortic aneurysm

Research from the Society for Vascular Surgery in collaboration with the Mount Sinai School of Medicine Department of Health Evidence and Policy in New York City evaluated the data of 3.1 million patients who were at risk for an abdominal aortic aneurysm (AAA).

20 Aug 2010

Muscle mass plays key role in cancer survival: Research

In the vast majority of patients with advanced cancer, their muscles will gradually waste away for reasons that have never been well understood. Now, researchers reporting in the August 20 issue of Cell, a Cell Press Publication, have found some new clues and a way to reverse that process in mice. What's more, animals with cancer that received the experimental treatment lived significantly longer, even as their tumors continued to grow.

20 Aug 2010

Model explains mechanical cause of high blood pressure

In a paper published today by Brahm Brahm, a model was introduced explaining the cause of high blood pressure. This model describes how both your heart and arteries contract to pump blood, creating pressure in the process. For the first time, this contraction cycle of the muscles in artery walls has been mathematically described.

20 Aug 2010

Binge drinking increases cardiovascular disease risk: Research

If you have high blood pressure, binge drinking may dramatically raise your risk of stroke or heart-related death, according to a South Korean study reported in Stroke: Journal of the American Heart Association.

20 Aug 2010

First pathological evidence of link between repeated head injuries and chronic traumatic Encephalomyopathy

Researchers with the Department of Veterans Affairs (VA) and the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine have provided the first pathological evidence of a link between repeated head injuries—such as those experienced by athletes in contact sports such as boxing, football, and hockey—and a disease (chronic traumatic Encephalomyopathy) that resembles amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

20 Aug 2010

Study on multisensory processing in autistic children

A new study by researchers at Albert Einstein College of Medicine of Yeshiva University has provided concrete evidence that children with autism spectrum disorders (ASD) process sensory information such as sound, touch and vision differently than typically developing children.

20 Aug 2010

Medical Condition News

Study finds ketamine restores connection in chronic stress affected brain cells

Pulmonary Fibrosis Foundation to support 2010 National PF Week

Bacterial pathogens require vitamin B6 biosynthesis enzymes for virulence: Study

Palliative care recipients live longer and in less pain, study finds

Scientists discover genetic flaw that causes facioscapulohumeral muscular dystrophy

FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta

Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients

Study finds black women with SLE develop cardiovascular disease at early age

Renin test can predict appropriate drugs for BP patients: Study

Study suggests elective surgical repair is safe intervention for abdominal aortic aneurysm

Muscle mass plays key role in cancer survival: Research

Model explains mechanical cause of high blood pressure

Binge drinking increases cardiovascular disease risk: Research

First pathological evidence of link between repeated head injuries and chronic traumatic Encephalomyopathy

Study on multisensory processing in autistic children

Intake of green leafy vegetables reduces risk of developing type 2 diabetes

Muscular Dystrophy Association awards $14.1M in new grants

FDA grants priority review designation of BENLYSTA for systemic lupus erythematosus treatment

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Chelsea Therapeutics announces new investigator to conduct phase II clinical study of Droxidopa

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News